Health
Daiichi Sankyo says it has begun producing AstraZeneca’s COVID-19 vaccine in Japan – TheChronicleHerald.ca
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan. The drugmaker said in a release it…
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan.
The drugmaker said in a release it will prepare the vaccine in Japan, including vial filling and packaging, using the bulk solution provided by AstraZeneca.
The Japanese government has already arranged to buy 120 million doses of AstraZeneca’s vaccine, enough for 60 million people. Most of the doses will be made in Japan by Daiichi Sankyo, JCR Pharma and other local partners.
…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts